According to LeMaitre Vascular's latest financial reports the company's current revenue (TTM) is $0.19 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.15 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.19 B | 19.69% |
2022 | $0.16 B | 4.68% |
2021 | $0.15 B | 19.37% |
2020 | $0.12 B | 10.35% |
2019 | $0.11 B | 11.05% |
2018 | $0.10 B | 4.66% |
2017 | $0.10 B | 13.14% |
2016 | $89.15 M | 13.78% |
2015 | $78.35 M | 10.2% |
2014 | $71.09 M | 10.14% |
2013 | $64.54 M | 13.77% |
2012 | $56.73 M | -1.65% |
2011 | $57.68 M | 2.9% |
2010 | $56.06 M | 10.12% |
2009 | $50.9 M | 4.49% |
2008 | $48.72 M | 17.55% |
2007 | $41.44 M | 19.69% |
2006 | $34.62 M | 12.7% |
2005 | $30.72 M | 17.35% |
2004 | $26.18 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Baxter BAX | $14.94 B | 7,626.22% | ๐บ๐ธ USA |
Boston Scientific BSX | $14.24 B | 7,259.78% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $6.00 B | 3,003.51% | ๐บ๐ธ USA |
Teleflex TFX | $2.97 B | 1,437.33% | ๐บ๐ธ USA |
AngioDynamics ANGO | $0.32 B | 67.46% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | $0.23 B | 23.96% | ๐บ๐ธ USA |